Results
fistula
SECONDARY, LEAKAGE
Among the total 72 patients who were randomized (36 in each group), five subjects in the patch group and three in the control group underwent a total pancreatectomy and were excluded from the analyses. The final analyses included 64 patients (31 in the patch group and 33 in the control group) (CONSORT diagramBaseline clinical and demographic characteristicsValues are Surgical time was shorter in the patch group (median 265 Overview of the intraoperative characteristics of the study sampleValues are POPF rate, including biochemical leakage, was 38 per cent (24/64 patients) in the overall study sample, with nine (14 per cent) patients presenting grade B/C POPF. Regarding the overall POPF rate, there was no significant difference between the patch group (29 per cent) and the control group (52 per cent) (Overview of the secondary outcomes of the study within 90 days after surgery in the overall study population, the patch group, and the control groupValues are The risk of CR-POPF was reduced by 90 per cent (OR 0.10, 95 per cent c.i. 0.01 to 0.89, Unadjusted and adjusted OR of the role of the polyethylene glycol-coated haemostatic patch in the risk of clinically relevant-postoperative pancreatic fistulaModel 1: adjusted by age and sex. Model 2: adjusted by age, sex, and fistula risk score (low The length of hospital stay and length of ICU stay were similar in the patch and control groups. The incidence of other secondary outcomes did not significantly differ between the study groups (